Thalassemia Major
📧 Sign up to get email alerts when something new happens for Thalassemia Major.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies [NA]
Pilot study results for peripheral blood stem cell transplantation with TCRab depletion in hemoglobinopathies were completed and results pos…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Study to Evaluate the Long- Term Safety and Efficacy of Luspatercept in Subjects Who Received at Least One Dose of Luspatercept in the Compassionate Use Phase
Clinical trial update on the long-term safety and efficacy of luspatercept in subjects who received at least one dose during the compassiona…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) [Phase 1, Phase 2]
Editas Medicine reports an update for EDIT-301, an autologous hematopoietic stem cell gene-editing therapy, currently in Phase 1/Phase 2 for…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: To Evaluate Long- Term Safety and Efficacy of Luspatercept
An update on a long-term safety and efficacy study of luspatercept in thalassemia major; the trial is active but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study [Phase 4]
A multicenter Phase 4 prospective study evaluating hematopoietic stem cell transplantation in patients with thalassemia major has been compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron Overload [NA]
A completed clinical trial comparing the iron chelators deferasirox and deferoxamine in patients with β-thalassemia major and iron overload.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation [Phase 2]
Phase 2 pilot trial assessing safety, pharmacokinetics, and iron chelating activity of DST-0509 (Deferasirox) in thalassemia major patients …
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: Impact of the Preparation Method of Red Cell Concentrates on Transfusion Indices in Thalassemic Patients [Phase 4]
Phase 4 trial evaluating how the preparation method of red cell concentrates affects transfusion indices in patients with Thalassemia Major.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating hydroxyurea, omega-3, Nigella sativa, and honey for iron overload and oxidative stress in pediatric major t…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI [Phase 2]
Phase 2 trial update on neridronate (Nerixia) for osteoporosis in patients with thalassemia major/intermedia showing efficacy and safety res…
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis [Phase 3]
Phase 3 trial comparing denosumab to zoledronic acid in thalassemia-induced osteoporosis was terminated.
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis [Phase 2]
Phase 2 trial comparing denosumab to placebo in patients with thalassemia major and osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants [Phase 1, Phase 2]
Clinical trial update summarizes safety and efficacy findings for LentiGlobin BB305 in patients with β-thalassemia major across Phase 1/Phas…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Pilot Study for Patients With Poor Response to Deferasirox [Phase 4]
Phase 4 pilot trial update on patients with poor response to Deferasirox.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion [Phase 3]
Phase 3 trial evaluating the efficacy and safety of S303-treated red blood cells in subjects with thalassemia major requiring chronic transf…
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: Periodontal Therapy in Thalassemia Major Patients [NA]
King Saud University sponsored a clinical trial evaluating periodontal therapy in patients with thalassemia major and chronic periodontitis.…
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia. [Phase 2]
A Phase 2 study of INC424 in regularly transfused patients with thalassemia major has completed, with results posted in 2017 evaluating effi…
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Zinc Supplementation on Cellular Immunity in Thalassemia Major [Phase 4]
Phase 4 study evaluating zinc supplementation on cellular immunity in thalassemia major has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia [Phase 4]
A Phase 4 clinical trial in Indonesia completed evaluating pneumococcal vaccination in splenectomised thalassemia major patients.
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: High-Tc Susceptometer to Monitor Transfusional Iron Overload
Clinical trial update reporting that the study evaluating a High-Tc Susceptometer to monitor transfusional iron overload has completed, in p…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Efficacy Study in Removing Excess Iron From the Heart [Phase 4]
A Phase 4 clinical trial update reports completion of an efficacy study evaluating removal of excess iron from the heart in patients with th…
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: Amlodipine Use in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major [Phase 2, Phase 3]
This clinical trial evaluated the use of amlodipine to prevent and treat iron overload in patients with thalassemia major; the study has com…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: MR Imaging of Diffuse Myocardial Fibrosis in Transfusion-Dependent Anemias
This update reports the completion of a clinical trial evaluating MR imaging to detect diffuse myocardial fibrosis in transfusion-dependent …
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia [Phase 2]
Phase 2 trial evaluating stem cell transplantation after reduced-dose chemotherapy for sickle cell disease or thalassemia. The study has bee…
-
CLINICAL_TRIALS trial_result · 2011-08-15Clinical Trial Update: A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload. [Phase 2]
A 4-year extension study of deferasirox for iron chelation in pediatric β-thalassemia major patients with transfusional iron overload comple…